About Lepro Pharma Compass OPC Private Limited
Data last updated:
Lepro Pharma Compass OPC Private Limited is a one person company based in New Delhi, Delhi, India. It operates in the online healthcare services segment of the internet and digital services sector. It was incorporated on 01 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2014OPC271095. Its GSTIN is 07AACCL7569G1Z7 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepak Pradhan and Sanjay Gandhi.
Its last annual general meeting (AGM) was held on 28 September 2023, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 205 Empire Plaza M.G.Road Sultanpur, New Delhi, Delhi, India – 110030.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.79 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹68.03 Lakh (net margin 7%) and EBITDA of ₹98.71 Lakh (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 30% over five years.
The company has about 32 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: PharmaCompass.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmacompass.com.
Company details
Contact details
Lepro Pharma Compass OPC Private Limited's registered office is in New Delhi, Delhi. Its website is pharmacompass.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address205 Empire Plaza M.G.Road Sultanpur, New Delhi, Delhi, India – 110030
- IndustryInternet, Online Healthcare Services
To see the full contact details of Lepro Pharma Compass OPC Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lepro Pharma Compass OPC operates one associated brand: PharmaCompass. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers API, FDF, excipients sourcing and market intelligence for pharmaceutical businesses worldwide. | pharmacompass.com |
Business activity
The main business activity of Lepro Pharma Compass OPC is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lepro Pharma Compass OPC Private Limited, buy the company report.
Financials of Lepro Pharma Compass OPC Private Limited
FY 2025 filings availableLepro Pharma Compass OPC Private Limited reported revenue of ₹9.79 Cr (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 17% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹98.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lepro Pharma Compass OPC Private Limited, buy the company report.
Board of directors of Lepro Pharma Compass OPC Private Limited
Lepro Pharma Compass OPC has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nidhi Mehta Also directs: Epique World Private Limited, Aarpee Enterprises Private Limited, RMN Holdings Private Limited and 1 more | Nominee | 01 Sep 2014 | 12 Years 1 Months | Current |
| Deepak Pradhan Also directs: Pharmacompass Digital Private Limited | Director | 11 Sep 2021 | 5 Years 1 Months | Current |
| Sanjay Gandhi Also directs: Pharmacompass Digital Private Limited | Director | 11 Sep 2021 | 5 Years 1 Months | Current |
Auditor
Lepro Pharma Compass OPC Private Limited is audited by Jain Chopra & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Jain Chopra & Company | FY 2023 | 002198N |
Shareholding
The shareholding of Lepro Pharma Compass OPC Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions and public shareholders.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public |
To see the full shareholding pattern of Lepro Pharma Compass OPC Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lepro Pharma Compass OPC Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lepro Pharma Compass OPC Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lepro Pharma Compass OPC Private Limited has a workforce of 32 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
GST
Lepro Pharma Compass OPC has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCL7569G1Z7 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lepro Pharma Compass OPC Private Limited, buy the company report.
Recent activity
Lepro Pharma Compass OPC Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Deepak Pradhan ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Lepro Pharma Compass OPC is an active company based in New Delhi, Delhi, India. The company works in online healthcare services, within the internet industry. It was incorporated on 01 September 2014 (12+ years old) and is registered under CIN U24232DL2014OPC271095.
Lepro Pharma Compass OPC has 3 current directors:
- Deepak Pradhan - Director
- Sanjay Gandhi - Director
- Nidhi Mehta - Nominee
The latest financial statements of Lepro Pharma Compass OPC on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Lepro Pharma Compass OPC is 07AACCL7569G1Z7, registered in Delhi.
The CIN (Corporate Identification Number) of Lepro Pharma Compass OPC is U24232DL2014OPC271095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lepro Pharma Compass OPC was incorporated on 01 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Deepak Pradhan ceased to be Additional Director on 30 Nov 2021. Sanjay Gandhi ceased to be Additional Director on 30 Nov 2021. Bharat Mehta ceased to be Director on 11 Sep 2021. Lepro Pharma Compass OPC has 6 board changes on record in total.
Lepro Pharma Compass OPC can be reached through the website pharmacompass.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Lepro Pharma Compass OPC is at 205 Empire Plaza M.G.Road Sultanpur, New Delhi, Delhi, India – 110030.
Lepro Pharma Compass OPC operates in the internet industry, in the online healthcare services segment.